Evidence map›Paper›PMID 33028245›Full record

ArticleBMC infectious diseases2020

Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC).

F Mangana, L D Massaquoi, R Moudachirou, R Harrison, T Kaluangila, G Mucinya, N Ntabugi, G Van Cutsem, R Burton, P Isaakidis

Abstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Public health action · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

F ManganaMédecins Sans Frontières, Kinshasa, Democratic Republic of Congo.
L D MassaquoiMédecins Sans Frontières, Kinshasa, Democratic Republic of Congo. lamindmassaquoi@gmail.com.ORCID http://orcid.org/0000-0001-5123-7081
R MoudachirouMédecins Sans Frontières, Conakry, Guinea.
R HarrisonMédecins Sans Frontières, Kinshasa, Democratic Republic of Congo.
T KaluangilaMédecins Sans Frontières, Kinshasa, Democratic Republic of Congo.
G MucinyaMédecins Sans Frontières, Kinshasa, Democratic Republic of Congo.
N NtabugiMédecins Sans Frontières, Kinshasa, Democratic Republic of Congo.
G Van CutsemSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.
R BurtonSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.
P IsaakidisSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV continues to be the main determinant morbidity with high mortality rates in Sub-Saharan Africa, with a high number of patients being late presenters with advanced HIV. Clinical management of advanced HIV patients is thus complex and requires strict adherence to updated, empirical and simplified guidelines. The current study investigated the impact of the implementation of a new clinical guideline on the management of advanced HIV in Kinshasa, Democratic Republic of Congo (DRC).

methodsA retrospective analysis of routine clinical data of advanced HIV patients was conducted for the periods; February 2016 to March 2017, before implementation of new guidelines, and November 2017 to July 2018, after the implementation of new guidelines. Eligible patients were patients with CD4 < 200 cell/μl and presenting with at least 1 of 4 opportunistic infections. Patient files were reviewed by a medical doctor and a committee of 3 other doctors for congruence. Statistical significance was set at 0.05%.

resultsTwo hundred four and Two hundred thirty-one patients were eligible for inclusion before and after the implementation of new guidelines respectively. Sex and age distributions were similar for both periods, and median CD4 were 36 & 52 cell/μl, before and after the new guidelines implementation, respectively. 40.7% of patients had at least 1 missed/incorrect diagnosis before the new guidelines compared to 30% after new guidelines, p < 0.05. Clinical diagnosis for TB and toxoplasmosis were also much improved after the implementation of new guidelines. In addition, only 63% of patients had CD4 count test results before the new guidelines compared to 99% of patients after new guidelines. Death odds after the implementation of new guidelines were significantly lower than before new guidelines in a multivariate regression model that included patients CD4 count and 10 other covariates, p < 0.05.

conclusionsSimplification and implementation of a new and improved HIV clinical guideline coupled with the installation of laboratory equipment and point of care tests potentially helped reduce incorrect diagnosis and improve clinical outcomes of patients with advanced HIV. Regulating authorities should consider developing simplified versions of guidelines followed by the provision of basic diagnostic equipment to health centers.

Indexed as

AdolescentAdultAmbulatory Care FacilitiesAnti-Retroviral AgentsCD4 Lymphocyte CountDemocratic Republic of the CongoFemaleGuidelines as TopicHIV InfectionsHospital MortalityHumansMaleMiddle AgedRetrospective StudiesToxoplasmosisTuberculosisAnti-Retroviral AgentsAdvanced HIVHIV clinical guidelineHIV clinical managementHIV infectionSub-Saharan Africa

Identifiers

PMID33028245
PMCPMC7539483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.